The Essen Stroke Risk Score Predicts Recurrent Cardiovascular Events | Zendy

Christian Weimar | Zendy; HansChristoph Diener | Zendy; Mark J. Alberts | Zendy; Philippe Gabríel Steg | Zendy; Deepak L. Bhatt | Zendy; Peter W.F. Wilson | Zendy; Jean-Louis Mas | Zendy; Joachim Röther | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Essen Stroke Risk Score Predicts Recurrent Cardiovascular Events

Author(s) -

Christian Weimar,

HansChristoph Diener,

Mark J. Alberts,

Philippe Gabríel Steg,

Deepak L. Bhatt,

Peter W.F. Wilson,

Jean-Louis Mas,

Joachim Röther

Publication year - 2008

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.108.521419

Subject(s) - medicine , stroke (engine) , atrial fibrillation , aspirin , myocardial infarction , cardiology , population , clopidogrel , cohort , framingham risk score , disease , mechanical engineering , environmental health , engineering

Predictive scores are important tools for stratifying patients based on the risk of future (cerebro)vascular events and for selecting potential prevention therapy. Recently, the Essen Stroke Risk Score (ESRS) was derived from cerebrovascular patients in the Clopidogrel versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE) trial. We aimed to validate the ESRS in a large cohort of outpatients with previous transient ischemic attack or stroke from the REduction of Atherothrombosis for Continued Health (REACH) Registry.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research